scispace - formally typeset
W

William C. Reinhold

Researcher at National Institutes of Health

Publications -  118
Citations -  12066

William C. Reinhold is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 47, co-authored 112 publications receiving 10922 citations. Previous affiliations of William C. Reinhold include Georgia Institute of Technology & University of Genoa.

Papers
More filters
Journal ArticleDOI

A gene expression database for the molecular pharmacology of cancer

TL;DR: Gene-drug relationships for the clinical agents 5-fluorouracil and L-asparaginase exemplify how variations in the transcript levels of particular genes relate to mechanisms of drug sensitivity and resistance.
Journal ArticleDOI

GoMiner: a resource for biological interpretation of genomic and proteomic data

TL;DR: GoMiner, a program package that organizes lists of 'interesting' genes for biological interpretation in the context of the Gene Ontology, provides quantitative and statistical output files and two useful visualizations.
Journal ArticleDOI

CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set

TL;DR: A CellMiner web application is introduced designed to improve the use of the extensive NCI-60 cell line database for discovery by creating web-based processes that are rapid, flexible, and readily applied by users without bioinformatics expertise.
Journal ArticleDOI

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells

TL;DR: This work profiled mRNA expression of the 48 known human ABC transporters in 60 diverse cancer cell lines used by the National Cancer Institute and found and validated compounds whose activity is potentiated, rather than antagonized, by the MDR1 multidrug transporter.
Journal ArticleDOI

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

TL;DR: A significant role for VEGPF is suggested in the development of CNS tumor neovascularity and peritumoral edema and in capillary hemangioblastomas.